3D生物打印皮肤组织工程:一个不断发展的研究领域
本文通过文献综述评估2009至2016年间皮肤3D生物打印研究,分析打印技术、细胞来源、支架类型及体内外结果。生物打印皮肤可促进创面愈合、模拟分层表皮,但无法复制厚而弹性、血管化的真皮。结论认为该技术仍处早期,分辨率、血管化、细胞与支架组合及成本是临床转化前需克服的障碍。
要点
- 生物打印皮肤可加速创面愈合并模拟分层表皮,但未能复制厚而弹性、血管化的真皮。
- 最常见生物墨水为角质形成细胞和成纤维细胞联合胶原,干细胞日益受关注。
- 激光辅助沉积是最常用打印方式,喷墨和气压挤出也已测试。
核心结论
- 3D生物打印在皮肤工程中展现前景,但研究仍处于起步阶段。
- 分辨率、血管化、最佳细胞与支架组合及生物打印皮肤成本是临床适用性实现前需克服的障碍。
- 小规模3D皮肤组织模型用于化妆品、药物和毒性测试以及肿瘤建模可能先于重建外科患者应用转化。
研究设计与样本
- 文献综述,检索PubMed、EMBASE和Web of Science中2009至2016年间皮肤3D生物打印研究。
- 评估生物打印技术、细胞来源、支架类型及体外和体内结果。
主要发现
- 最常见生物墨水由角质形成细胞和成纤维细胞联合胶原组成,干细胞日益受关注。
- 激光辅助沉积是最常用打印方式,喷墨和气压挤出也已测试。
- 生物打印皮肤促进加速创面愈合,能模拟分层表皮但不能模拟厚而弹性、血管化的真皮。
临床怎么用
- 小规模3D皮肤组织模型用于化妆品、药物和毒性测试以及肿瘤建模可能先转化。
- 生物打印皮肤在重建外科患者中的应用需先克服分辨率、血管化、最佳细胞与支架组合及成本障碍。
局限性
- 研究仍处于起步阶段。
- 分辨率、血管化、最佳细胞与支架组合及生物打印皮肤成本是需克服的障碍。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Commercially available tissue engineered skin remains elusive despite extensive research because the multi-stratified anisotropic structure is difficult to replicate in vitro using traditional tissue engineering techniques. Bioprinting, involving computer-controlled deposition of cells and scaffolds into spatially controlled patterns, is able to control not only the macro but also micro and nanoarchitecture and could offer the potential to more faithfully replicate native skin. METHODS: We conducted a literature review using PubMed, EMBASE and Web of Science for studies on skin 3D bioprinting between 2009 and 2016, evaluating the bioprinting technique, cell source, scaffold type and in vitro and in vivo outcomes. RESULTS: We outline the evolution of biological skin replacements, principles of bioprinting and how they apply to the skin tissue engineering field, potential clinical applications as well the current limitations and future avenues for research. Of the studies analysed, the most common types of bioinks consisted of keratinocytes and fibroblasts combined with collagen, although stem cells are gaining increasing recognition. Laser assisted deposition was the most common printing modality, although ink-jet and pneumatic extrusion have also been tested. Bioprinted skin promoted accelerated wound healing, was able to mimic stratified epidermis but not the thick, elastic, vascular dermis. CONCLUSIONS: Although 3D bioprinting shows promise in engineering skin, evidenced by large collective investments from the cosmetic industry, the research is still in its infancy. The resolution, vascularity, optimal cell and scaffold combinations and cost of bioprinted skin are hurdles that need to be overcome before the clinical applicability can be realised. Small scale 3D skin tissue models for cosmetics, drug and toxicity testing as well as tumour modelling are likely to be translated first before we see this technology used in reconstructive surgery patients.
引用
- Tarassoli SP, Jessop ZM, Al-Sabah A, et al. Skin tissue engineering using 3D bioprinting: An evolving research field. J Plast Reconstr Aesthet Surg. 2017. PMID: 29306639. doi:10.1016/j.bjps.2017.12.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。